Try our Advanced Search for more refined results
Exubera
- September 10, 2012 MannKind To Pay $23M In Investor Suit Over Diabetes Drug
- February 03, 2011 Investors Slam MannKind After FDA Balks On Afrezza
- April 09, 2008 Lung Cancers Prompt Pfizer To Revise Exubera Label
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login